These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28442880)

  • 61. Sun-exposure- and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer.
    Liang SB; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Chen BK; Sonobe H
    Virchows Arch; 1999 Mar; 434(3):193-9. PubMed ID: 10190297
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior.
    Weninger W; Rendl M; Pammer J; Grin W; Petzelbauer P; Tschachler E
    J Cutan Pathol; 1997 Jul; 24(6):364-9. PubMed ID: 9243364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The burden of non-melanoma skin cancers in Auckland, New Zealand.
    Pondicherry A; Martin R; Meredith I; Rolfe J; Emanuel P; Elwood M
    Australas J Dermatol; 2018 Aug; 59(3):210-213. PubMed ID: 29350397
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pigmented Bowen's disease mimicking cutaneous melanoma: clinical and dermoscopic aspects.
    Stante M; de Giorgi V; Massi D; Chiarugi A; Carli P
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):541-4. PubMed ID: 15056147
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Primary cutaneous neuroendocrine (Merkel cell) carcinoma in association with squamous- and basal-cell carcinoma.
    Cerroni L; Kerl H
    Am J Dermatopathol; 1997 Dec; 19(6):610-3. PubMed ID: 9415620
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population.
    Askari SK; Schram SE; Wenner RA; Bowers S; Liu A; Bangerter AK; Warshaw EM
    J Am Acad Dermatol; 2007 May; 56(5):739-47. PubMed ID: 17258839
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Borderline and atypical melanocytic lesions.
    Brodell RT; Santa Cruz DJ
    Semin Diagn Pathol; 1985 Feb; 2(1):63-86. PubMed ID: 3916688
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The utility of GLUT-1 immunolocalization in cell blocks: An adjunct to the fine needle aspiration diagnosis of cystic squamous lesions of the head and neck.
    Chandan VS; Faquin WC; Wilbur DC; Khurana KK
    Cancer; 2006 Apr; 108(2):124-8. PubMed ID: 16435376
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group.
    Lichter MD; Karagas MR; Mott LA; Spencer SK; Stukel TA; Greenberg ER
    Arch Dermatol; 2000 Aug; 136(8):1007-11. PubMed ID: 10926736
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study of 140 cases.
    Longo C; Farnetani F; Ciardo S; Cesinaro AM; Moscarella E; Ponti G; Zalaudek I; Argenziano G; Pellacani G
    Br J Dermatol; 2013 Jul; 169(1):58-67. PubMed ID: 23374159
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
    Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
    J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Principles of dermatoscopy of pigmented skin lesions.
    Stolz W; Semmelmayer U; Johow K; Burgdorf WH
    Semin Cutan Med Surg; 2003 Mar; 22(1):9-20. PubMed ID: 12773010
    [TBL] [Abstract][Full Text] [Related]  

  • 73. All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis.
    Wehner MR; Cidre Serrano W; Nosrati A; Schoen PM; Chren MM; Boscardin J; Linos E
    J Am Acad Dermatol; 2018 Apr; 78(4):663-672.e3. PubMed ID: 29146125
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Meyerson Phenomenon as a Component of Melanoma in situ.
    Sezer E; Özturk Durmaz E; Çetin E; Şahin S
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients.
    Cognetta AB; Howard BM; Heaton HP; Stoddard ER; Hong HG; Green WH
    J Am Acad Dermatol; 2012 Dec; 67(6):1235-41. PubMed ID: 22818756
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dermoscopy of Melanoma and Non-melanoma Skin Cancers.
    Kato J; Horimoto K; Sato S; Minowa T; Uhara H
    Front Med (Lausanne); 2019; 6():180. PubMed ID: 31497603
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sensitivity and specificity of ex vivo dermatoscopy: a case series.
    Dobrosavljevic D; Brasanac D; Glumac S; Radojevic S; Matija L; Stanisavljevic D
    Int J Dermatol; 2018 Aug; 57(8):915-921. PubMed ID: 29790147
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
    Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma.
    Farhadi M; Kamrava SK; Behzadi AH; Rafiezadeh P; Asghari A; Rezvan F; Maleki S
    J Drugs Dermatol; 2010 Feb; 9(2):122-6. PubMed ID: 20214173
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Overexpression of cyclin D1 in nonmelanocytic skin cancer.
    Liang SB; Furihata M; Takeuchi T; Iwata J; Chen BK; Sonobe H; Ohtsuki Y
    Virchows Arch; 2000 Apr; 436(4):370-6. PubMed ID: 10834541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.